EDITOR BOARD MEMBERS : VIEW ALL
Dr Bikasih Thapa & Dr Maheswar Prasad (Nepal) - Hideo Wada MD PhD (japan) - Dr a Lavra Castrocatesana (Mexico) - Dr Mrs N.M. Hettiarachechui (Srilanka) - Dr Jorge Aldrete Velasco (Mexico) - Prof Hans Peter Kohler (Switzerland) - Dr Hermanus Suhartono S Sp.OG(K) PhD - Dr Isabel Pinheiro (Portugal) - Dr Suranga (Srilanka) - Jovia Dino Jansen Amsterdam,Holand - Hideo Wada MD PhD University Graduate School of Medicine Departement of Moleculer and Laboratory Medicine Japan - DR Bikash Thapa Internal Medicine Nepal University - DR Maheswar Prasad Internal Medicine Nepal University - Dr a Lavra Castro Castresana Colegio de Medicina interna de Mexico - Dr Suransa Manilgama University of Srilanka Internal Departement Medicine - Dr Mrs N.M. Hettiarachechui University of Medicine Srilanka - Dr Jorge Aldrete Velaso .Colegio de Medicina Interna de Mexico - Prof Hans Peter Kholer M.D FACD Profesor of Medicine University ot Switzerland - Dr Ramezan Ali Atace . Baqiyatallah University of Medical Sciences Departement of Micrology Tehran Iran - Ezekiel Wong Toh Yoon Dr. Gastroenterology of Japan - D Eric Beck,MD Bethesda Hospital Capitol Boelevard St Paul USA - Dr Emine Guderen Sahin Istambul University of Internal Medicine Turky - Dr Selmin Toplan Istambul University - Dr Nicholas New Australia - Dr Kughan Govinden. Tropical Infection of Internal Medicine Malaysia - Dr Godfrey M Rwegerera Princes Marina Hospital Bostwana -
EFFECT OF CEFTAZIDIME AND CLOXACILLIN AS AN ANTIBIOTIC PERMANENT HEMODIALYSIS CATHETER BLOCKER SOLUTION IN PREVENTION OF CATHETER RELATED BLOOD STREAM INFECTIONS

Author : Mohammad Saad Forghani, Mohsen Rajabnia, Bahram Nikkhoo, Jamal Modarres Gorji*

Abstract

Background and Objective: Patients with end stage renal function (ESRD) require vascular access for hemodialysis and infection is the most common delayed complication of central venous catheters. The aim of this study was to evaluate the effect of using two antibiotics, ceftazidime and coloxacillin, as a permanent hemodialysis catheter blocker solution in the prevention of catheter-related blood infections. Materials and Methods: This clinical trial was performed on 64 patients undergoing hemodialysis in Tohid Hospital in Sanandaj, 2016-2017. Patients were divided into two groups of intervention and controls (placebo). The duration of follow up was 6 months in this study. All patients were evaluated during dialysis and in each session for further evaluations of unwanted drug reactions, skin complications such as rash, itching and other side effects. For data analysis, STATA software version 12, independent t-test and chi-square test were used. Results: The results of this study showed that the mean duration of hemodialysis in the intervention group was 19.76 ± 4.28 and the control group was 27.5 ± 4.96 months. Most of the microorganisms have been grown in the blood culture of the subjects in both Staph Aureus groups. Keywords: Hemodialysis, Catheter Infection, Antibiotic, CRBSI

[ PDF ]

 

Indexing

;;;;;;;;

 

PENGUNJUNG KAMI DARI BERBAGAI BELAHAN DUNIA

Flag Counter